Sale!

Gastrointestinal Cancer Gene Panel Test Cost

Original price was: 9,600 د.إ.Current price is: 7,200 د.إ.

-25%

The Gastrointestinal Cancer Gene Panel Test is a sophisticated diagnostic tool designed to identify specific genetic mutations associated with various types of gastrointestinal cancers, including cancers of the stomach, colon, rectum, esophagus, and pancreas. By analyzing a patient’s DNA, this comprehensive test can detect alterations in multiple genes that are known to increase the risk of developing gastrointestinal cancers.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test offers a proactive approach for individuals with a family history of gastrointestinal cancers or those who want to assess their genetic predisposition to these diseases. The test cost is set at 7200 AED, reflecting the extensive analysis and detailed insights it provides. Results from this test can guide personalized prevention strategies, inform treatment decisions, and help in the early detection of cancers, significantly impacting patient outcomes.

Description

Gastro-Intestinal Cancer Gene Panel Test

Test Name: Gastro-Intestinal Cancer Gene Panel Test

Components: EDTA Vacutainer (3 ml)

Price: 7200.0 AED

Sample Condition: Peripheral blood

Report Delivery: 4-6 weeks

Method: NGS (Next-Generation Sequencing)

Test Type: Genetics

Doctor: General Physician

Test Department:

Pre Test Information: Gastro-Intestinal Cancer Gene Panel can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

The Gastro-Intestinal Cancer Gene Panel is a genetic test that analyzes a group of genes associated with an increased risk of developing gastrointestinal cancers, including colorectal cancer, gastric cancer, pancreatic cancer, and others. The panel typically includes genes such as APC, KRAS, TP53, and others, which are known to play a role in the development of these cancers.

The test is typically performed on a blood or tissue sample and uses next-generation sequencing technology to analyze the DNA of the selected genes. The results of the test can help identify individuals who may be at increased risk of developing gastrointestinal cancers and may benefit from increased surveillance or early detection strategies.

The Gastro-Intestinal Cancer Gene Panel is typically recommended for individuals with a family history of gastrointestinal cancers or other risk factors, such as a personal history of certain types of polyps or inflammatory bowel disease. It may also be used to help guide treatment decisions for individuals with a confirmed diagnosis of gastrointestinal cancer.

Test Name	Gastro-Intestinal Cancer Gene Panel Test
Components	EDTA Vacutainer (3 ml)
Price	7200.0 AED
Sample Condition	Peripheral blood
Report Delivery	4-6 weeks
Method	NGS
Test type	Genetics
Doctor	General Physician
Test Department:
Pre Test Information	Gastro-Intestinal Cancer Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	The Gastro-Intestinal Cancer Gene Panel is a genetic test that analyzes a group of genes associated with an increased risk of developing gastrointestinal cancers, including colorectal cancer, gastric cancer, pancreatic cancer, and others. The panel typically includes genes such as APC, KRAS, TP53, and others, which are known to play a role in the development of these cancers. The test is typically performed on a blood or tissue sample and uses next-generation sequencing technology to analyze the DNA of the selected genes. The results of the test can help identify individuals who may be at increased risk of developing gastrointestinal cancers and may benefit from increased surveillance or early detection strategies. The Gastro-Intestinal Cancer Gene Panel is typically recommended for individuals with a family history of gastrointestinal cancers or other risk factors, such as a personal history of certain types of polyps or inflammatory bowel disease. It may also be used to help guide treatment decisions for individuals with a confirmed diagnosis of gastrointestinal cancer.